William R Boden

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

• William Boden, MD (Boston University School of Medicine/VA New England Healthcare System, MA), who led the COURAGE trial that showed PCI didnt reduce the risk of death, MI, or other major CVD events when added to medical therapy in stable patients, called the symptomatic improvement in ORBITA-2 rel
• Date: Nov 11, 2023
• Category: Health
• Source: Google

Drug dosing for older heart patients should differ

• In addition to Roe and Ohman, study authors include Shaun Goodman; Susanna Stevens; Judith Hochman; Shmuel Gottlieb; Bikur Cholim; Felipe Martinez; Anthony Dalby; William Boden; Harvey White; Dorairaj Prabhakaran; Kenneth Winters; Philip Aylward; Jean-Pierre Bassand;
• Date: Aug 16, 2013
• Category: Health
• Source: Google

Stent Benefit Questioned in Stable Disease

• are not needed, and one study suggested that if one-third of elective PCI procedures in patients with stable disease could be averted or deferred, the associated cost savings would fall between $6 billion and $8 billion annually (Circ Cardiovasc Qual Outcomes 2009; 2: 134-140), commented William Boden
• Date: Feb 28, 2012
• Category: Health
• Source: Google

• Dr. William Boden of the Samuel S. Stratton VA Medical Center in Albany, New York, who wrote a commentary in the journal, said relieving angina appeared to be the "last remaining sacred cow" for doctors who argue in favor of stents over drugs.
• Date: Feb 28, 2012
• Category: Health
• Source: Google

Lilly Drug Doubles Good Cholesterol in Race With Merck, Roche

• The higher number of strokes in patients who got Niaspan, a $927 million sales generator in 2010, werent statistically significant, said William Boden, a study investigator and professor at the University at Buffalo Schools of Medicine and Public Health, in an interview.
• Date: Nov 15, 2011
• Category: Health
• Source: Google

Heart Treatment Overused

• Journal of Medicine published a study known as "Courage" by a Buffalo, N.Y. cardiologist named William Boden. The Courage study, which tracked 2,287 patients for five years, showed stents weren't any better than a cocktail of medicines to treat patients suffering from chronic but stable chest pain.
• Date: Jul 05, 2011
• Category: Health
• Source: Google

Combo Cholesterol Treatment Trial Halted

• Participants in the trial had low-density lipoprotein cholesterol (LDL) levels of about 71 mg/dL at baseline, but were at risk of cardiovascular disease due to low high-density lipoprotein cholesterol (HDL) levels and high levels of triglycerides, reported William Boden, MD, co-principal investigato
• Date: May 26, 2011
• Category: Health
• Source: Google

Drug Trial Is Halted After Niacin Fails to Protect the Heart

• But it's not clear if niacin would have any effect on people at higher risk or those who don't have a diagnosis of heart disease yet but take niacin as a preventive, said study co-leader Dr. William Boden of the University at Buffalo.
• Date: May 26, 2011
• Category: Health
• Source: Google